Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial
在原发性免疫性血小板减少症患者中,从艾曲波帕换用赫曲波帕:一项多中心随机III期试验的事后分析
期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-024-05826-5
Mei, Heng; Liu, Xiaofan; Li, Yan; Zhou, Hu; Feng, Ying; Gao, Guangxun; Cheng, Peng; Huang, Ruibin; Yang, Linhua; Hu, Jianda; Hou, Ming; Yao, Yazhou; Liu, Li; Wang, Yi; Wu, Depei; Shen, Xuliang; Jin, Jie; Luo, Jianmin; Zeng, Yun; Zhou, Xin; Xia, Ruixiang; Jiang, Zhongxing; Bai, Yuansong; Niu, Ting; Yang, Renchi; Hu, Yu